1
|
Marina M, Maglietta G, De Filpo G, Aloe R, Gnocchi C, Iezzi E, Caminiti C, Ceresini G. Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial. Endocrine 2022; 77:340-348. [PMID: 35751777 PMCID: PMC9325824 DOI: 10.1007/s12020-022-03110-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 05/29/2022] [Indexed: 11/24/2022]
Abstract
PURPOSE Patients undergoing thyroidectomy for differentiated thyroid cancer (DTC) may require 131-radioactive iodine (RAI) administration for remnant ablation or disease treatment. After ingestion, RAI resides within the gastrointestinal tract potentially leading to mucosal damage and abnormalities in the absorption of levothyroxine (LT4). The aim of this study was to evaluate whether serum FT4 peak, induced by a LT4 challenge, changes according to the LT4 formulation (solid or liquid) in both RAI and non-RAI-treated DTC patients. METHODS This was a monocentric controlled clinical trial, with a parallel two-groups (1:1) randomization of sequence of LT4 formulation. Patients received 200 mcg LT4 orally administered at 08:00 h, in both solid and liquid formulation, at one-week interval, at baseline and after 1, 3, and 6 months from RAI administration. At each time-point, circulating FT4 was evaluated both before LT4 assumption as well as after 1 and 3 h. FT4 increments were evaluated as area under the curve response (AUC). Analogous protocol with the same time-intervals was followed for non-RAI patients. RESULTS The trial included 29 consecutive DTC patients, nineteen of whom were submitted to RAI. In RAI subjects, we observed an overall significant reduction in serum FT4 increments with the most relevant decrease at the 1-month time-point, (FT4 AUC: 4.46 ± 0.72 (M ± SD) vs 4.07 ± 0.63 in baseline vs 1-month, P = 0.001) without any difference between the two LT4 formulations. No difference in serum FT4 AUC was found in non-RAI subjects. CONCLUSION LT4-induced serum FT4 responses are reduced following RAI administration in thyroidectomized DTC patients.
Collapse
Affiliation(s)
- Michela Marina
- SSD Medicina interna ad indirizzo onco-endocrinologico, Università di Parma - Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Giuseppe Maglietta
- UO Ricerca clinica ed epidemiologica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Giuseppina De Filpo
- SSD Medicina interna ad indirizzo onco-endocrinologico, Università di Parma - Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Rosalia Aloe
- SSD Biochimica ad elevata automazione, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Cecilia Gnocchi
- SSD Biochimica ad elevata automazione, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Elisa Iezzi
- UO Programmazione e Controllo di Gestione, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Caterina Caminiti
- UO Ricerca clinica ed epidemiologica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
| | - Graziano Ceresini
- SSD Medicina interna ad indirizzo onco-endocrinologico, Università di Parma - Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
| |
Collapse
|
2
|
Di Pietro M, Dipalo M, Rocchi MBL, Musa R, Avanzini P, Gnocchi C, Anelli MC, Aloe R. Assessment of Access hsTnI 99th percentiles upper reference limits following IFCC recommendations. Clin Chim Acta 2019; 492:26-28. [PMID: 30711523 DOI: 10.1016/j.cca.2019.01.028] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Revised: 01/30/2019] [Accepted: 01/30/2019] [Indexed: 11/28/2022]
Abstract
BACKGROUND The detection of an increase and/or decrease of cardiac troponin (cTnI) values, with at least one value above the 99th percentile of the upper reference limit (URL) have a central role in acute myocardial infarction (AMI) diagnosis. The employment of sex specific 99th percentile URLs and High-sensitivity (Hs) assays are recommended. We assessed sex specific 99th percentile URL for Access Hs-cTnI and AccuTnI3+ (Beckman Coulter) using European donor reference population following recent International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommendations. METHODS 300 males and 300 females plasma samples were collected. Both chemiluminescent immunoenzymatic assays were performed on UniCel DxI 800 platform (Beckman Coulter). RESULTS For Access hsTnI, the observed sex-specific 99th percentile URLs were 5.5 (90% CI: 4.4-7.6) for females and 13.9 ng/L (90% CI: 7.4-17.4) for males. For AccuTnI+3 we could not establish them because the assay couldn't report detectable values of troponin for most of the analyzed samples. CONCLUSION The sex-specific 99th percentile URLs established for Access hsTnI assay were significantly lower than those declared by the manufacturer caused by the different choice of population selection, age groups and sample types: for those reasons, we maintain the 99th URLs provided by manufacturer.
Collapse
Affiliation(s)
- Martina Di Pietro
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy.
| | - Mariella Dipalo
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy
| | - Marco Bruno Luigi Rocchi
- Dipartimento di Scienze Biomolecolari, Università degli studi di Urbino "Carlo Bo", Via Ca' Le Suore, 2-4, 61029 Urbino, Italy
| | - Roberta Musa
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy
| | - Paola Avanzini
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy
| | - Cecilia Gnocchi
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy
| | | | - Rosalia Aloe
- SSD Biochimica ad Elevata Automazione, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy
| |
Collapse
|
3
|
Lippi G, Dipalo M, Buonocore R, Gnocchi C, Aloe R, Delsignore R. Analytical Evaluation of Free Testosterone and Cortisol Immunoassays in Saliva as a Reliable Alternative to Serum in Sports Medicine. J Clin Lab Anal 2016; 30:732-5. [PMID: 26990800 DOI: 10.1002/jcla.21929] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2015] [Revised: 11/16/2015] [Accepted: 12/09/2015] [Indexed: 11/07/2022] Open
Abstract
BACKGROUND This study was aimed to investigate whether measurement of free testosterone and cortisol in saliva is a reliable alternative to their assessment in serum for monitoring physical fitness in professional athletes. METHODS We studied 25 members of the soccer team Parma F.C., playing in Italian major football league. Blood and saliva samples were collected at fasting, before a regular training session. Cortisol, total and free testosterone, as well as the ratio between free testosterone and cortisol, were assessed in paired serum and saliva samples, and their results were compared. RESULTS An excellent correlation was found between serum and saliva cortisol (r = 0.751; P < 0.001). A significant correlation was also observed between free testosterone in serum and saliva (r = 0.590; P = 0.002), whereas no significant correlation was found between total testosterone in serum and saliva (r = 0.181; P = 0.387). A significant correlation was found for the free testosterone to cortisol ratio in serum and saliva (r = 0.43; P = 0.031). All athletes (25/25; 100%) declared that they would feel more comfortable to have saliva rather than blood serially collected. CONCLUSIONS The results of this study suggest that measurement of free testosterone and cortisol in saliva may be seen as a reliable alternative to their assessment in serum.
Collapse
Affiliation(s)
- Giuseppe Lippi
- Section of Clinical Biochemistry, University Hospital of Verona, Verona, Italy.
| | - Mariella Dipalo
- Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
| | - Ruggero Buonocore
- Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
| | - Cecilia Gnocchi
- Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
| | - Rosalia Aloe
- Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
| | | |
Collapse
|
4
|
Dipalo M, Gnocchi C, Aloe R, Lippi G. Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric assay. Ann Transl Med 2016; 3:351. [PMID: 26807406 DOI: 10.3978/j.issn.2305-5839.2015.12.34] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
BACKGROUND The demand for routine measurement of squamous cell carcinoma antigen (SCCA) is rapidly increasing in clinical laboratories, due to the central role that this biomarker plays in staging and monitoring patients with various forms of squamous cell carcinomas (SCCs). METHODS The present analytical evaluation of Maglumi SCCA was aimed to assess the imprecision, linearity and comparability against a widely used technique. RESULTS The intra- and inter-assay imprecision was comprised between 2.6-4.2% and between 5.0-7.3%, respectively. The linearity of the test was excellent in the range of SCC values comprised between 1.0 and 18.0 ng/mL (r=0.998; P<0.001). A highly significant correlation was observed between Maglumi SCCA and BRAHMS Kryptor SCC in the range of values comprised between 0.44 and 15.18 ng/mL (r=0.960; P<0.001). The mean bias was 0.79 ng/mL (95% CI, 0.61-0.97) and the diagnostic agreement at the respective diagnostic cut-offs was 95%. CONCLUSIONS The results of this study confirm that Maglumi SCCA may be regarded as a suitable alternative to Kryptor SCC for routine and fully-automated assessment of SCCA in clinical laboratories.
Collapse
Affiliation(s)
- Mariella Dipalo
- 1 Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy ; 2 Section of Clinical Biochemistry, University of Verona, Verona, Italy
| | - Cecilia Gnocchi
- 1 Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy ; 2 Section of Clinical Biochemistry, University of Verona, Verona, Italy
| | - Rosalia Aloe
- 1 Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy ; 2 Section of Clinical Biochemistry, University of Verona, Verona, Italy
| | - Giuseppe Lippi
- 1 Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy ; 2 Section of Clinical Biochemistry, University of Verona, Verona, Italy
| |
Collapse
|
5
|
Marina M, Ceda GP, Aloe R, Gnocchi C, Ceresini G. Circulating concentrations of free thyroxine after an oral intake of liquid LT4 taken either during fasting conditions or at breakfast. Acta Biomed 2016; 87:247-252. [PMID: 28112689 PMCID: PMC10521879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 08/05/2016] [Accepted: 08/07/2016] [Indexed: 06/06/2023]
Abstract
BACKGROUND AND AIM OF THE WORK Liquid levothyroxine (LT4) given at breakfast normalizes TSH in hypothyroid patients. However, a few studies are available on circulating free thyroxine (FT4) concentrations after liquid vs solid LT4 preparations. METHODS During an "ad interim" analysis on serum FT4 after 200 mcg liquid LT4 consumption while fasting in thyroidectomized thyroid cancer patients, we found that seven subjects fortuitously took liquid LT4 at breakfast. As established in the original protocol, serum FT4 was measured both at baseline as well as at 3 and 4 hours after solid or liquid LT4 consumption. We compared serum profile of FT4 in these subjects with those obtained in other subjects participating in the same study who took liquid LT4 (n. 7 subjects) or solid LT4 (n. 7 subjects) while fasting. The percentage increase of circulating FT4 was calculated at the above reported peak-times over the baseline values. RESULTS Circulating FT4 increased of about 40% in each group of subjects at both the 3rd and the 4th hour with no difference between these two time points in either group. The maximum FT4 % increase, irrespective of the time point, was 44.62 ± 3.05 (Mean ± SE), 44.84 ± 5.43, and 43.83 ± 1.30 after fasting solid, fasting liquid, and breakfast liquid LT4 consumption, respectively, with no differences among the three groups. CONCLUSIONS Circulating FT4 obtained after 3 and 4 hours from the ingestion of 200 mcg liquid LT4 is not influenced by meal and is comparable with that observed after solid LT4 preparations ingested while fasting.
Collapse
Affiliation(s)
- Michela Marina
- Department of Clinical and Experimental Medicine, University of Parma.
| | | | | | | | | |
Collapse
|
6
|
Dipalo M, Buonocore R, Gnocchi C, Picanza A, Aloe R, Lippi G. Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800. Clin Chem Lab Med 2015; 53:593-7. [PMID: 25536668 DOI: 10.1515/cclm-2014-1118] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2014] [Accepted: 12/02/2014] [Indexed: 11/15/2022]
Abstract
BACKGROUND This study was aimed to evaluate the analytical performance of the novel Diazyme procalcitonin (PCT) immunoturbidimetric assay on Beckman Coulter AU5800. METHODS Diazyme PCT is a latex-enhanced immunoturbidimetric assay, developed for use on laboratory instrumentations with capability of reading absorbance at 600 nm. This analytical evaluation included the assessment of limit of blank (LOB), limit of detection (LOD), functional sensitivity, imprecision, linearity, carryover, and method comparison between Diazyme PCT and Kryptor PCT on 129 routine serum inpatient samples. RESULTS The LOB, LOD, and functional sensitivity of Diazyme PCT were 0.16, 0.26, and 0.28 ng/mL, respectively. The intra- and inter-assay imprecision of Diazyme PCT was between 2.9% and 7.8%. The linearity was excellent in the range of PCT values between 0.16 and 56 ng/mL, and the carryover was negligible (0.02%). A highly significant agreement was found between Kryptor PCT and Diazyme PCT in a range of concentrations between 0.16 and 111 ng/mL (Diazyme PCT=1.10×Kryptor PCT-0.89; r=0.960; p<0.001). The mean bias was 0.48 ng/mL (95% CI, -0.58 to 1.54 ng/mL). The strength of agreement between Kryptor PCT and Diazyme PCT was between 85% and 96% at 0.50, 2.0, and 10 ng/mL cutoffs. CONCLUSIONS Diazyme PCT appears to be a reliable assay for diagnosis and management of critical care patients susceptible to severe bacterial infections.
Collapse
|
7
|
Dipalo M, Dipietro M, Gnocchi C, Musa R, Aloe R, Lippi G. Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800. Clin Chem Lab Med 2015; 53:e355-8. [DOI: 10.1515/cclm-2015-0425] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2015] [Accepted: 06/04/2015] [Indexed: 11/15/2022]
|
8
|
Caroli B, Pasin F, Aloe R, Gnocchi C, Dei Cas A, Galli C, Passeri G. Characterization of skeletal parameters in a cohort of North Italian rugby players. J Endocrinol Invest 2014; 37:609-17. [PMID: 24696159 DOI: 10.1007/s40618-014-0070-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2014] [Accepted: 03/11/2014] [Indexed: 12/11/2022]
Abstract
BACKGROUND Vitamin D deficiency is common in the general population and may impair skeletal muscle function. Very few data are available regarding this condition in professional athletes. AIM To evaluate some skeletal parameters and in particular serum 25-hydroxyvitamin D status in professional rugby players during two different sunlight exposure times (October and early April) and to assess its impact on bone metabolism. MATERIALS AND METHODS Twenty-one male healthy professional rugby players living in northern Italy at latitude of 44°55'N (age 24.6 ± 4.3 years; height 182.0 ± 0.05 cm; mass 96.3 ± 14.6 kg; BMI 28.9 ± 3.7 kg/m(2)) participated in this observational study. During 2012/2013 Italian rugby season, 25-hydroxyvitamin D, PTH and other related biochemical parameters were monitored. Dietary calcium intake and body composition by DXA were also evaluated. RESULTS Significant changes were observed between October and April data for 25-hydroxyvitamin D concentration (22.8 ± 5.8 vs. 19.1 ± 5.3 ng/ml; p = 0.001) whereas serum PTH, calcium and phosphorus plasma levels did not change. They presented with an appropriate daily intake of calcium (1,304.8 ± 477.9 mg; max 1,939 mg; min 228 mg). CONCLUSIONS Professional rugby athletes practicing a sport characterized by intense outdoor training and with good calcium intake are at higher risk of hypovitaminosis D that worsens significantly during times of low cutaneous vitamin D production. Further studies are warranted to evaluate whether an appropriate supplementation with cholecalciferol in professional athletes is needed.
Collapse
Affiliation(s)
- B Caroli
- Department of Clinical and Experimental Medicine, University of Parma, Azienda Ospedaliera/Universitaria di Parma, Via Gramsci 14, 43125, Parma, Italy
| | | | | | | | | | | | | |
Collapse
|
9
|
Gallotta A, Ziglioli F, Ferretti S, Maestroni U, Moretti M, Aloe R, Gnocchi C, Di Palo M, Fassina G. A novel algorithm for the prediction of prostate cancer in clinically suspected patients. Cancer Biomark 2013; 13:227-34. [DOI: 10.3233/cbm-130357] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
| | - Francesco Ziglioli
- Unit of Urology, Surgical Department, University-Hospital of Parma, Parma, Italy
| | - Stefania Ferretti
- Unit of Urology, Surgical Department, University-Hospital of Parma, Parma, Italy
| | - Umberto Maestroni
- Unit of Urology, Surgical Department, University-Hospital of Parma, Parma, Italy
| | - Matteo Moretti
- Unit of Urology, Surgical Department, University-Hospital of Parma, Parma, Italy
| | - Rosalia Aloe
- SSD Biochimica ad Elevata Automazione, University-Hospital of Parma, Parma, Italy
| | - Cecilia Gnocchi
- SSD Biochimica ad Elevata Automazione, University-Hospital of Parma, Parma, Italy
| | - Mariella Di Palo
- SSD Biochimica ad Elevata Automazione, University-Hospital of Parma, Parma, Italy
| | | |
Collapse
|
10
|
Bertuzzi A, Bisogno G, Carli M, Ferrari A, Comandone A, Gasco M, De Sanctis R, Gnocchi C, Santoro A. Imatinib Mesylate in Desmoplastic Small Round Cell Tumour. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)34039-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
11
|
De All J, Lanfranconi M, Bledel I, Doval H, Hughes A, Laroti A, Sánchez Aramburu V, Gnocchi D, Dubra L, Gorosito F, Henry N, Leguia M, Francos J, González Viana H, Saavedra F, Gnocchi C. Prevalencia de la hipertensión arterial en poblaciones rurales del norte argentino. Hipertensión y Riesgo Vascular 2012. [DOI: 10.1016/j.hipert.2012.03.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
12
|
Indio V, Pantaleo MA, Astolfi A, Casadio R, Paterini P, Formica S, Martelli P, Moore R, Thiessen N, di Battista M, Catena F, Santini D, Heinrich MC, Gnocchi C, Dei Tos AP, Biasco G. Identification of single nucleotide variants in gastrointestinal stromal tumor KIT/PDGFRA wild-type (WT GISTs) by massively parallel sequencing. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
13
|
Pantaleo MA, Astolfi A, Indio V, Paterini P, Formica S, Casadio R, Martelli P, Maleddu A, Nannini M, Dei Tos AP, Heinrich MC, Santini D, Catena F, Ceccarelli C, Fiorentino M, di Battista M, Moore R, Thiessen N, Gnocchi C, Biasco G. Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10045] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
14
|
Pantaleo MA, Maleddu A, Nicoletti G, Nanni C, Gnocchi C, di Battista M, Nannini M, Landuzzi L, Quarta C, Biasco G. Preclinical evaluation of combined treatments in xenograft model of gastrointestinal stromal tumors (GISTs) using small animal PET. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e20502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
15
|
Bonetti A, Monica C, Bonaguri C, Gnocchi C, Russo A, Battistelli L, Musiari L, Pastori P, Novarini A. Interference by heterophilic antibodies in immunoassays: wrong increase of myoglobin values. Acta Biomed 2008; 79:140-143. [PMID: 18788511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Aim of this work is to illustrate how analytical interference in immunoassay may produce serious errors in clinical laboratory results. The sophisticated quality assurance schemes used in many laboratories do not identify erroneous results arising from aberrant samples. Recently attention has been focused on the incidence and implication of false-positive results arising from the presence of certain substances in a patient's serum that interfere with one or more steps in immunoassays. In this paper, we present the case of a 92 year-old woman whose plasma myoglobin concentrations falsely increased when measured using the Beckman Access assay. We demonstrated that heterophilic antibodies accounted for the falsely increased myoglobin values, and we suggest how to resolve such situations.
Collapse
|
16
|
Gnocchi C, Risso J, Khoury M, Torn A, Noel M, Baredes N, Mariscal C, Rosenbaum G, Nallar M, Sarotto L, Ferraina P. [Application of a preoperative evaluation model in patients undergoing elective abdominal surgery]. Medicina (B Aires) 2000; 60:125-34. [PMID: 10835709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
Abstract
We used a preoperative evaluation model based on the clinical history in order to determine the clinical characteristics of the patients. We also estimated the prevalence of asymptomatic disease in ASA1 patients and described the frequency of diagnosis that motivated suspension of the surgery during the preoperative time. Another purpose was to establish the perioperative complications according to the risk index and to detect the medical reasons for suspension of surgery during hospitalization. A total of 777 patients having an indication of surgery were evaluated in this program. Only 507 completed the preoperative evaluation. Of these, 57.79%, had at least one known disease or were diagnosed by their clinical history. Preoperative tests were indicated according to age in ASA1 patients. Complementary studies were indicated in relationship to the history and physical examination in ASA2 and ASA3 patients. After the evaluation, 27 surgeries were suspended: 21 were considered high risk, 2 suffered unknown active infections, and 4 ASA1 patients had severe asymptomatic anemia. A total of 328 patients were admitted for surgery. In 5 of these patients the anesthesiologist stopped the procedure in the operating room. The causes were acute decompensations of known pathologies. There were no complications or deaths related to unknown diseases and no patients died from cardiopulmonary or metabolic complications. In ASA1 patients, there were no complications related to this evaluation. This study allowed us to determine the clinical status of the patients and in consequence high-risk surgeries were canceled. In admitted patients a few surgeries were canceled for clinical reasons. This program probably decreased patient morbimortality, unnecessary hospitalization and costs.
Collapse
Affiliation(s)
- C Gnocchi
- Departamento de Medicina, Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|